EMITF (Elbit Imaging) Short Interest

View and export this data going back to 1996. Start your Free Trial

What is Elbit Imaging Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Elbit Imaging's Short Interest

For the Medical Devices subindustry, Elbit Imaging's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elbit Imaging's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elbit Imaging's Short Interest distribution charts can be found below:

* The bar in red indicates where Elbit Imaging's Short Interest falls into.

Save Embed

Elbit Imaging Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elbit Imaging Ltd (OTCPK:EMITF) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

EMITF-M:Israel

Address

3 Shimshon Street, Olympia A Tower, Petach Tikva, ISR, 4900102

Website

http://www.elbitimaging.com

Elbit Imaging Ltd is an Israel based company. The business activity of the group is operated through two segments including Medical industries and devices, and Plots in India. Geographically the business presence is in the region of America, Europe, and ROW. The company derives maximum revenue from the Medical industries and devices segment which operates in the field of life science that includes development, production, and marketing of treatment-oriented medical systems, and for certain cancer diseases in the America region.